Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M200292-JLR200 on November 4, 2002

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200292-JLR200v1
44/2/380    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balestrieri, M. L.
Right arrow Articles by Servillo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balestrieri, M. L.
Right arrow Articles by Servillo, L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 44, 380-387, February 2003
Copyright © 2003 by Lipid Research, Inc.

Modulation by flavonoids of PAF and related phospholipids in endothelial cells during oxidative stress

Maria Luisa Balestrieri*, Domenico Castaldo{dagger}, Ciro Balestrieri*, Lucio Quagliuolo*, Alfonso Giovane* and Luigi Servillo1,*

* Department of Biochemistry and Biophysics, Second University of Naples, Italy
{dagger} Stazione Sperimentale Industria Essenze e Derivati Agrumari, Reggio Calabria, Italy

Published, JLR Papers in Press, November 4, 2002. DOI 10.1194/jlr.M200292-JLR200

1 To whom correspondence should be addressed. e-mail: luigi.servillo{at}unina2.it


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PAF-dependent transacetylase (TA) modifies the functions of platelet-activating factor (PAF), a potent inflammatory lipid, either by transferring the acetyl group from PAF to lysophospholipids (TAL activity), or to sphingosine (TAS activity) or by hydrolyzing PAF (acetylhydrolase activity). In stimulated endothelial cells (EC), TAL activity contributes to the synthesis of acyl-PAF, an acyl analog of PAF, that antagonizes PAF functions and is regulated by the cellular redox state. In this study, we investigated the possible involvement of TA in the flavonoid antioxidant mechanism(s) during oxidative stress in EC induced by hydrogen peroxide. The treatment of EC with H2O2 resulted in 4-fold increase of the acetyl-CoA acetyltransferase activity (AT), that is responsible for PAF biosynthesis, while the TAL activity increased only by 53%. However, the preincubation of H2O2-treated EC with the flavonoids hesperedin, naringin, and quercetin strongly inhibited AT activity and activated TAL by 290%, 340%, and 250%, respectively.

The induction of TAL activity resulted in enhanced biosynthesis of 1-acyl-2-[3H]acetyl-PAF in intact EC and was related to the flavonoid structure. These findings suggest that TAL is involved in the flavonoid anti-inflammatory action by enhancing the production of acyl-PAF.

Abbreviations: AH, acetylhydrolase; AT, acetyltransferase activity; CP, creatine phosphate; CPK, creatine phosphokinase; EC, endothelial cell; LPE, lyso-glycerophosphoethanolamine; PAF, platelet-activating factor; PLA2, phospholipase A2; PLC, phospholipase C; TA, transacetylase; TAL, transacetylase lysophospholipids; TAS, transacetylase sphingosine

Supplementary key words atherosclerosis • inflammation • transacetylase lysophospholipids • platelet-activating factor


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation, allergic reactions, and reproduction (1, 2). Its biological functions can be modified by the transacetylase (TA), an enzyme that shows three catalytic activities [transacetylase lysophospholipids (TAL), transacetylase sphingosine (TAS), and acetylhydrolase (AH)] differentially regulated (3). TA transfers the acetyl group of PAF to synthesize either acyl-analogs of PAF or [C2]ceramide, or hydrolyses PAF to lyso-PAF. TA was purified to apparent homogeneity from rat kidney membranes and cytosol (4). PAF is synthesized by different cell types as a response to specific stimuli. In activated endothelial cells (EC), acyl-PAF, an acyl analog of PAF, is predominantly produced instead of PAF. Acyl-PAF acts as a naturally occurring specific noncompetitive inhibitor of PAF-induced activation of human neutrophils (5) and leukotriene C4 release from human leucocytes (6). It is known that PAF-like lipids are responsible for downregulating growth factors and inhibiting proliferation in EC exposed to oxidized LDL (7). Moreover, acyl-PAF decreases the susceptibility of the LDL particle to oxidative modifications (8). In activated ECs, TAL contributes to the biosynthesis of acyl-PAF (9, 10), and its activity is regulated by the thiol cellular levels [i.e., glutathione (GSH)] (11). In particular, the enzyme activity increases in the presence of thiol-oxidant agents and is decreased by thiol-antioxidants (11). The cellular redox homeostasis represents the antioxidant defense mechanism that protects cells from the increased levels of reactive oxygen species (ROS) in the vasculature, including superoxide anion, H2O2, and hydroxyl radical. Because of their location at the interface of the vascular system, ECs in the blood vessel wall are from time to time exposed to peroxide, as during local inflammatory reaction or because of the contact with oxidized lipoproteins. At the site of the inflammation, H2O2 generated by activated neutrophils (12) modulates the inflammatory process by upregulating the expression of adhesion molecules, (13, 14) controlling cell proliferation or apoptosis (15), and modulating platelet aggregation (16). In addition, the H2O2 production plays a key role in the pathogenesis of atherosclerosis by modifying LDL and increasing their atherogenicity (17, 18). Flavonoids are a group of antioxidants present in plants comprising flavones, flavonols, and flavonones as major members. Flavones, such as quercetin, are present in onions, lettuce, and olives, whereas flavanones (naringin and hesperetin) are mostly contained in citrus fruit and citrus peel (19).

They scavenge superoxide radical and other radical anions, which in part contribute to their antioxidant properties. In vitro studies have shown that flavonoids act on enzyme systems critically involved in the initiation and maintenance of the inflammatory response; they are inhibitors of the acetyltransferase activity (AT) (20, 21) and phospholipase A2 (PLA2) (22), inhibit platelet function (23) and EC adhesion protein gene expression (24), and protect against the development of atheroscherosis (25, 26). Moreover, addition of flavonoids to EC incubated with oxidized LDL may attenuate such a cytotoxic effect of the modified lipoprotein (27). These data led us to hypothesize that flavonoids may regulate PAF metabolism in EC. Consequently, the present study was designed to evaluate the role of flavonoids in modulating TA activities during induced oxidative stress in EC.


   METHODS
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Materials
PAF, GSH, 5-sulfosalicyclic acid, glutathione reductase, naringin, naringenin, hesperidin, hesperetin, quercetin, hydrogen peroxide, acetyl-CoA, phospholipase C (PLC) type XI from Bacillus cereus, benzoic anhydride, DMSO, indometacin, creatine phosphate (CP), creatine phosphokinase (CPK), and 4-dimethylamino-pyridine were obtained from Sigma. Alkenyl-lyso-glycerophosphoethanolamine (LPE) was a product from Serdary Research Lab. [3H]acetyl-PAF (13.5 Ci/mmol) and [3H]acetyl-CoA (1.54 Ci/mmol) were purchased from NEN Life Science Products. All culture reagents were from Life Technologies, Inc. Phospholipids were tested for purity by TLC and only >95% pure phospholipids were used in the experiments.

Cell culture
EC from calf pulmonary artery endothelium were obtained from the American Type Culture Collection (CPAE, CCL 209). Monolayers of cells between passages 19–25 were grown in MEM with 20% FBS. Cells were cultured in 75 cm2 flasks, and only subconfluent monolayers between passages 19 and 25 were used for the experiments to avoid the cellular changes which EC undergo at higher passages. The subconfluent monolayers were prepared the day before the experiment by seeding EC in 100 mm Petri dishes at the nonsaturating density of 5 x 106 cells/dish.

Homogenates were prepared in the homogenization buffer (0.25 M sucrose, 100 mM Tris-HCl, pH 7.3, 1 µg/ml leupeptin, 1 mM dithiotreitol) by sonication, and the protein content of the cell homogenates was determined as previously described (9).

Cell treatments
The H2O2 used in the present work was a 30% stable solution, and appropriate dilutions were made immediately prior to use in serum-free media to avoid rapid degradation by antioxidants present in the serum. Subconfluent monolayers of ECs were washed twice with 5 ml of HBSS-10 mM HEPES and incubated for the indicated time with H2O2 in serum-free media. When flavonoids were tested before H2O2 treatment, cells were preincubated at 37°C for 1 h with flavonoids prepared in DMSO. At the end of the preincubation, the media were removed and the cells were washed twice with 5 ml of HBSS-10 mM HEPES, thus eliminating the possibility of a direct interaction between H2O2 and flavonoids outside the cellular environment. The final DMSO concentration in the media was less than 0.1% and the cell viability was >95%, as assessed by trypan blue dye exclusion.

AT assay
The AT assay system consisted of 500 µM [3H]acetyl-CoA (0.2 µCi), 50 µM lysoPAF suspended in 3.3% BSA-saline, 100 mM Tris-HCl (pH 7.2), and 100 µg of homogenate in a final volume of 0.5 ml. Incubations were carried out at 37°C for 15 min, and the lipids were extracted by the method of Bligh and Dyer (28) The extracted lipids were separated by TLC using a solvent system of CHCl3-CH3OH-NH4OH-H20 (60:35:8:2.3, v/v/v/v). The radioactivity of the areas corresponding to PAF was determined by liquid scintillation counting.

TA assays
TAL, TAs, and AH activities were determined according to the methods we previously described (9, 3). TAL and TAS activity was determined using [3H]acetyl-PAF as acetyl donor and LPE or sphingosine as substrate acceptors, respectively. The extracted lipids (28) were separated by TLC, and the radioactivity of the areas corresponding to [3H]acetyl-PAF, [3H]acetyl-PE, and [3H]acetyl-sphingosine were determined by liquid scintillation counting.

Measurement of [3H]arachidonic acid release
EC grown in six wells-cell culture cluster dishes were prelabeled with [3H]arachidonic acid (0.25 µCi/ml) for 40 h at 37°C. Prelabeled cells were then washed with 2 ml of HBSS-10 mM HEPES and treated with flavonoids (25 µM) and H2O2 (1 mM) as described. The [3H]arachidonic acid release in the media was determined as previously described (10).

Purification and measurement of PAF
PAF released and associated to EC after treatment with flavonoids and H2O2 was extracted (28) and purified by TLC using a solvent system of CHCl3-CH3OH-H20 (60:35:6, v/v/v).

PAF was detected by its ability to induce platelet aggregation by a pathway independent of both adenosine diphosphate and cyclooxigenase-derived metabolites as described (29). Platelets (2 to 5 x 107) were stirred at 900 rpm in 300 µl of Tris-buffered Tyrode's (2.6 mM KCl, 1 mM MgCl2, 137 mM NaCl, 1.3 mM CaCl2, 0.1% glucose, and 1 mM Tris) supplemented with 0.25% gelatine in presence of indometacin (10 µM) and of CP-CPK enzymatic system (312.5 µg/ml of CP and 152.5 µg/ml of CPK). The amount of PAF was expressed in nanograms per milliliter and calculated over a calibration curve of synthetic PAF. The standard curve was constructed by adding 10 µl of solution of synthetic PAF at different concentrations (1 ng/ml to 15 ng/ml) to washed rabbit platelets.

Determination of the rate of transfer of the [3H]acetyl group from [3H]acetyl-PAF to 1-acyl-2-lysoPAF
Monolayers of EC cells were preincubated at 37°C for 1 h with the indicated flavonoids (25 µM) as described before, followed by treatment with H2O2 (1 mM) for 10 min in serum-free media in presence of [3H]acetyl-PAF (2.5 µCi) in 0.1% BSA. At the end of the incubations, the media were removed and the cells were rinsed twice with 5 ml of HBSS-10 mM HEPES before scraping into 3 ml of methanol. The cellular lipids were extracted (28) and the amounts of [3H]acetyl groups transferred from [3H]acetyl PAF to 1-acyl-2-lysoPAF were measured after PLC hydrolysis, benzoylation, and TLC analysis as previously described (9).

Determination of total GSH level
After the incubation with H2O2 in presence or absence of flavonoid pretreatment as described above, EC were scraped into 0.5 ml of sulfosalicylic acid 10% (w/v) and centrifugated at 15,000 g for 10 min. The supernatant was used for the determination of total GSH according to the method described (30).

Statistical analysis
Data are expressed as mean ± SEM from at least three independent experiments in duplicate. Statistical analysis was performed by Student's t-test. Probability values were considered significant at P < 0.05.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
H2O2 modifies PAF metabolism
To assess the effect of H2O2 on the biosynthesis of PAF and its analogs, EC were incubated for different times with 1 mM H2O2, then AT and TA activities were measured. This relatively high concentration of H2O2 was found not to be cytotoxic (13). On the other hand, it has been speculated that under certain conditions oxidants are released into relatively sequestered microenvironments, thus reaching high local concentrations (31). As shown in Fig. 1 , H2O2 induced a time-dependent activation of AT. The increase of AT activity reached the maximum at 10 min (4-fold over the basal level) and returned to near basal level at 20 min. Figure 2A indicates that the time-dependent increase of TAL activity was minimal and, specifically, at 10 min was only 1.5 more than in the untreated cells. Also, the concentration-dependence curve shows that the maximal H2O2-induced TAL activity occurred just at about 1 mM H2O2 (108 vs. 72 pmol/min/mg prot in control cells) (Fig. 2B). Since the TAL strongly contributes to the acyl-PAF biosynthesis in activated EC (9), these data indicated that during induced oxidative stress, the activation of AT is predominant and that TAL scarcely contributes to the acyl-PAF biosynthesis.



View larger version (11K):
[in this window]
[in a new window]
  		Fig. 1. Time-dependent activation of acetyltransferase activity (AT) in H2O2-treated endothelial cells (EC). Monolayers of subconfluent EC were stimulated with 1 mM H2O2 at the indicated times. At the end of the incubations, the total cell homogenates were prepared and the acetyltransferase (AT) activity was determined as described in Methods. Data are mean ± SEM of three separate experiments in duplicate (n = 6).

 


View larger version (15K):
[in this window]
[in a new window]
  		Fig. 2. Activation of transacetylase lysophospholipids (TAL) in H2O2-treated EC. A: Monolayers of subconfluent EC were stimulated with (1 mM) H2O2 at the indicated times. B: EC were stimulated for 10 min with different H2O2 concentrations. At the end of the incubations, the TAL activity was determined on the total cell homogenates as described in Methods. Data are mean ± SEM of three separate experiments in duplicate (n = 6).

 
H2O2 effect on TA activities
It is known that PAF-AH (II) protects MDBK cells against oxidative stress-induced death. This enzyme translocates from cytosol to membrane in response to H2O2 treatment and hydrolyzes the oxidized phospholipids (32). To determine whether the AH activity of TA functions as an antioxidant phospholipase during induced oxidative stress, EC were incubated for 10 min with 1 mM H2O2 and then AH activity was determined. The TAS activity was also determined in order to assess the [C2]ceramide production. As shown in Fig. 3 , AH and TAS activities were not influenced by H2O2 treatment (91% and 97% of the control, respectively). Therefore, the activation of TA by H2O2 is selective for the TAL portion of the TA activities.



View larger version (23K):
[in this window]
[in a new window]
  		Fig. 3. Effect of H2O2 on the three transacetylase (TA) activities. Subconfluent EC were stimulated with 1 mM H2O2 for 10 min and the total cell homogenates were used for the determination of the TAL, transacetylase sphingosine (TAS), and acetylhydrolase (AH) activities. Data were represented as means ± SEM of three separate experiments in duplicates (n = 6). The P values between cells treated with H2O2 (1 mM) and control cells were <0.05.

 
Induction of TAL activity by flavonoids
To test the hypothesis that TA could contribute to the anti-inflammatory actions of flavonoids, EC were preincubated for 1 h with quercetin (5,7,3',4', tetrahydroxyflavanol), naringin (4',5,7, trihydroxyflavanone-7-rhamnoglucoside), and hesperedin (3',5,7, trihydroxy-4-methoxyflavanone-7-rhamnoglucoside), and then with 1 mM H2O2 for 10 min. Flavonoids significantly activated the TAL activity in a dose-dependent manner (Fig. 4) , with a maximal activation at 25 µM. Citrus flavanones, hesperedin and naringin, resulted in the most potent compounds (290% and 340% more than in H2O2-treated EC, respectively) compared with the flavanol quercetin (250% more then in H2O2-treated EC). Flavonoids alone did not present any effect on the TAL activity in H2O2-untreated cells (data not shown). These results indicate that the TAL is involved in the flavonoid anti-inflammatory actions in EC during oxidative stress, most probably by increasing the acyl-PAF biosynthesis.



View larger version (15K):
[in this window]
[in a new window]
  		Fig. 4. Dose-dependent activation of TAL in flavonoid-pretreated EC. Various concentrations of hesperedin, naringin, and quercetin were preincubated with EC for 1 h at 37°C. Subsequently, ECs were treated with 1 mM H2O2 for 10 min and the TAL activity was determined. Data are expressed as means ± SEM (n = 4) and are representative of four experiments in duplicate. The P values between cells treated with H2O2 (1 mM) and cells treated with flavonoids (25 µM) plus H2O2 (1 mM) were <0.001.

 
Flavonoid effects on PAF metabolism
To determine whether flavonoids exert the anti-inflammatory action also influencing the AH portion of the TA with consequent PAF hydrolysis, the AH activity on the total homogenates from EC preincubated with flavonoids and then treated with H2O2, was assayed. Furthermore, since quercetin it is known to inhibit AT (20) and PLA2 (22) activities, we tested the effect of naringin, hesperedin, and quercetin on the AT and PLA2 activities as well. As illustrated in Fig. 5 , naringin, hesperedin, and quercetin induced only the TAL but not the AH activity of TA. Therefore, AH activity does not mediate the flavonoid action during induced oxidative stress; besides, the AT activity was strongly inhibited not only by quercetin, as previously shown (20), but also by naringin and hesperedin.



View larger version (34K):
[in this window]
[in a new window]
  		Fig. 5. Effect of flavonoids on AT and TA activities. AT and TA activities were determined on the total cell homogenates from untreated EC, and EC pretreated for 1 h with or without hesperedin (hesp), naringin (nar), and quercetin (quer) (25 µM) followed by stimulation with H2O2 (1 mM) for 10 min, as described in Methods. Data are expressed as means ± SEM (n = 4) with P < 0.001 for the AT activity (H2O2 vs. untreated), and TAL activity (flavonoids plus H2O2 vs. H2O2). The differences between untreated vs H2O2 and flavonoids plus H2O2 versus H2O2 were not significant for AH and TAS activities (P > 0.1).

 
We measured the [3H]arachidonic acid release as an index of the PLA2 activity and found that flavonoids also inhibited the lysoPAF production by PLA2. In fact, the [3H]arachidonic acid released in the media was 1,500 cpm/well in EC pretreated with flavonoids compared with 3,800 cpm/well in EC treated only with H2O2.

Taken together, these data indicate that flavonoids protect EC during oxidative stress by inhibiting PAF biosynthesis and, interestingly, by directing the utilization of the produced PAF as an acetyl donor for the synthesis of the less-active PAF analogs (TAL activity) instead of its hydrolysis (AH activity).

PAF measurement
To confirm that flavonoids inhibit PAF synthesis, the amount of PAF produced by EC stimulated with H2O2 and preincubated with or without flavonoids was determined. As shown in Table 1, EC produce PAF in response to H2O2 treatment (34.2 ng/ml) when compared with untreated cells (9.5 ng/ml). However, preincubation with hesperedin, naringin, and quercetin inhibit PAF synthesis, which return to near basal level (12.7 ng/ml, 11.4 ng/ml, and 13.4 ng/ml, respectively).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Measurement of platelet-activating factor

 
Effect of flavonoids on the transfer of [3H]acetyl group from [3H]acetyl-PAF to 1-acyl-2-lysoPAF
The transfer of the [3H]acetyl group from [3H]acetyl-PAF to 1-acyl-2-lysoPAF was used as an index of the TAL activity in intact EC. As shown in Fig. 6 , we found that the amounts of transferred [3H]acetyl group from [3H]acetyl-PAF to 1-acyl-2-lysoPAF increased from 315 x 103 cpm/flask in H2O2-treated cells to about 650 x 10 (3) cpm/flask in flavonoids-pretreated EC. These results confirm the flavonoid induced TAL activation and indicate that the enzyme induction is indeed reflected in the enhanced biosynthesis of acyl-PAF.



View larger version (28K):
[in this window]
[in a new window]
  		Fig. 6. Effect of flavonoids on the transfer of the [3H]acetyl group from [3H]acetyl-platelet-activating factor (PAF) to 1-acyl-2-lysoPAF. EC were preincubated with hesp, nar, and quer (25 µM), and then stimulated with H2O2 (1 mM) in the presence of [3H]acetyl-PAF (2.5 µCi) in 0.1% BSA. The cellular lipids were extracted and the rate of transfer of [3H]acetyl group from PAF to 1-acyl-2-lysoPAF was measured as described in Methods. Data are expressed as means ± SEM (n = 4) from two separate experiments.

 
Comparison of structurally related flavonoids
The structure-activity relationship of two types of flavonoids were examined. Hesperetin 25 µM (3',5,7,trihydroxy-4-methoxyflavanone) and naringenin 25 µM (4', 5,7-trihydroxyflavanone) were incubated with EC for 1 h before H2O2 treatment, and successively the TAL and AT activities were determined. As shown in Table 2, the TAL-specific activity in hesperetin- and naringenin-treated ECs was 194 and 121 pmol/min/mg prot, respectively, compared with 311 and 365 pmol/min/mg prot measured when EC were pretreated with hesperedin and naringin, respectively. In the EC treated with H2O2 only, the TAL-specific activity was 108 pmol/min/mg protein. On the other hand, Table 2 shows that hesperetin and naringenin are less potent AT inhibitors than hesperedin and naringin. Therefore, glycosylated flavanones (hesperedin and naringin) resulted in more potent TAL activators and AT inhibitors compared with their aglycone counterparts (hesperetin and naringenin). These observations indicated that the flavonoid biological activity on PAF and acyl-PAF metabolism is related to their structure and point out the importance of their glycidic moiety.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Effect of structurally related flavonoids on TAL and AT activities

 
Changes in redox state of EC
Antioxidants protect vascular cells against oxidative stress by scavenging ROS generated from the inflammatory stimuli (33) and by directly modulating redox-sensitive pathways. (34, 35) Moreover, changes in thiol cellular level influence TAL activity and thiol oxidizing reagents lead to an increased acyl-PAF production by TAL in EC. (11) In order to elucidate the possible mechanism(s) by which flavonoids regulate TAL activity, the changes in the redox state of the EC were monitored by measuring the total intracellular GSH level in the presence or absence of treatment with flavonoids. As shown in Fig. 7 , a decrease in the total GSH was observed in H2O2-treated EC (8.7 GSH equivalents, i.e., nmol of GSH/2.5 x 106 cells versus 14.3 GSH equivalents in untreated samples), reflecting oxidative stress. Conversely, in EC pretreated with hesperedin, naringin, and quercetin, the total GSH levels results were comparable with the untreated cells (12.9, 14.8, and 13.5 GSH equivalents, respectively). These data suggest that the flavonoid-induced TAL activation we observed does not depend on the oxidative state of the intracellular milieu.



View larger version (30K):
[in this window]
[in a new window]
  		Fig. 7. Changes in redox state of EC. Treatments of the cells with hesp, nar, quer, and H2O2 were made under the same conditions as described in Fig. 4. Data are the means ± SEM (n = 4) from two separate experiments.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Since EC layer the inner walls of blood vessels, they can easily become exposed to peroxides under stress conditions, such as those produced by activated neutrophils at the site of the inflammation (12). Oxidative stress and the production of ROS have been implicated in a variety of diseases, including Alzheimer's disease, cancer, and vascular diseases such as atherosclerosis. In particular, two interacting processes are now believed to initiate atherosclerosis: endothelial dysfunction (i.e., vasoconstriction, platelet activation, leukocyte adhesion, inflammation, thrombogenesis) and lipid accumulation and modification with a consequent production of oxidized LDL. (17, 18) These processes are mediated by a number of agents, including inflammatory mediators. The LDL susceptibiliy to oxidative modifications can be decreased by acyl-PAF, (8) an acyl analog of PAF (1). Acyl-PAF is the predominant component produced by activated EC, and the TAL contributes to its biosynthesis (9, 10). The inhibition of LDL oxidation is a well-characterized process that includes effects on the concentration or reactivity of oxidants capable of modifying LDL and on the susceptibility or resistance of LDL to these oxidants. (36) Like oxidants, antioxidants constitute a diverse group of compounds with different properties. They operate by inhibiting oxidant formation, intercepting oxidants once they have formed, and repairing oxidant-induced injury. In the present study, we provide evidence that TAL is involved in the flavonoid anti-inflammatory action in EC by transferring the acetyl group from PAF to 1-acyl-2-lyso-PAF, thus synthesizing acyl-PAF. In detail, we showed that the oxidative stress induced a noticeable induction of AT, the key enzyme of the PAF biosynthetic route, while TAL is only scarcely activated (Figs. 1, 2) compared with other inflammatory stimuli (9). AH activity has been found to protect against oxidative stress (32), most probably by hydrolyzing oxidized phospholipids and, in human LDL, PAF-AH possesses both transacetylase and acetylhydrolase activities that remove PAF and its ether-linked analogs from LDL particles upon LDL oxidation (37). Moreover, thiol cellular level regulates the cytokine-mediated apoptosis and the ceramide production (38). However, our results showed that both AH and TAS activities are not induced during the oxidative stress, indicating that AH does not protect EC against oxidative stress and that apoptosis-mediators, such as [C2]ceramide, are not produced by the TAS. These results are consistent with our previous observations that thiol modifying agents modulate only TAL activity in EC (11). The most intriguing of our findings is that flavonoids, such as quercetin, hesperedin, and naringin, exert their anti-inflammatory action not only by modifying monocyte adhesion in the inflammatory process of atherosclerosis (26) but also by regulating the enzyme activities responsible for the PAF and acyl-PAF biosynthesis. In particular, we showed for the first time the TAL involvement in the flavonoid anti-inflammatory action in EC.

These cells synthesize acyl-PAF as a predominant product in response to inflammatory stimuli (39, 40), and TAL activity contributes to its biosynthesis in EC. (9) Therefore, it was unlikely that the flavonoid-mediated TAL induction was not correlated to an increase of acyl-PAF production. However, we verified this fact by directly measuring the incorporation of the [3H]acetyl group into 1-acyl-2-lysoPAF by incubating EC with [3H]acetyl-PAF. The results indicated that flavonoid action on TAL is associated with an increased acyl-PAF production (Fig. 6). On the whole, these results suggest that TAL mediates flavonoid anti-inflammatory action in EC during oxidative stress. This enzyme provides for the PAF degradation with a concomitant biosynthesis of acyl-PAF, which can exert its beneficial role during the initiation and progression of atherosclerosis (8). The mechanism by which flavonoids inhibit AT activity is unclear. (20) Evidence suggests that the biological action of citrus flavonoids is possibly linked to their interaction with key regulatory enzymes involved in cell activation and in receptor binding (21). Flavonoid antioxidant properties are mostly related to their direct scavenging action against free radicals and ROS (33) or to their interaction with intracellular-occurring antioxidative agents such as glutathione peroxidase (34, 35). We showed that, in flavonoid-pretreated EC, the variation of total GSH level is not significant if compared with untreated cells. Therefore, it is conceivable that the mechanism(s) responsible for the TAL activation during flavonoid treatment of ECs is independent of the reducing state of the intracellular milieu. However, further studies are required to elucidate the flavonoid-induced pathway leading to TAL activation in EC.

In summary, in this report we provide for the first time evidence that TAL activity of TA contributes to the flavonoid anti-inflammatory action in EC. Elucidating the regulatory process(es) involved in the protection against redox-sensitive endothelium dysfunctions could be of clinical relevance for the development of novel therapeutic strategies for the treatment of the atherosclerosis and other inflammatory diseases.


   ACKNOWLEDGMENTS
 
This work was supported by the project Ricerche e sperimentazioni nel settore dell'agrumicoltura Italiana of the Ministero delle Politiche Agricole e Forestali.

Manuscript received July 24, 2002 and in revised form October 9, 2002.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
  1. Snyder, F. 1995. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim. Biophys. Acta. 1254: 231–333.[Medline]

  2. Izumi, T., and T. Shimizu. 1995. Platelet-activating factor receptor: gene expression and signal transduction. Biochim. Biophys. Acta. 1259: 317–333.[Medline]

  3. Lee, T-c., B. Malone, L. Longobardi, and M. L. Balestrieri. 2001. Differential regulation of three catalitic activities of platelet-activating factor (PAF)-dependent transacetylase. Arch. Biochem. Biophys. 387: 41–46.[CrossRef][Medline]

  4. Karasawa, K., X. Qiu, and T-c. Lee. 1999. Purification and characterization from rat kidney membranes of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs and C2-ceramide. J. Biol. Chem. 274: 8655–8661.[Abstract/Free Full Text]

  5. Triggiani, M., D. W. Goldman, and F. H. Chilton. 1991. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. Biochim. Biophys. Acta. 1084: 41–47.[Medline]

  6. Columbo, M., E. M. Horowitz, V. Patella, A. Kagey-Sobotka, F. H. Chilton, and L. M. Lichtenstein. 1993. A comparative study of the effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet activating factor on histamine and leukotriene C4 release from human leukocytes. J. Allergy Clin. Immunol. 92: 325–333.[CrossRef][Medline]

  7. Chang, P. Y., S. Luo, T. Jiang, Y. T. Lee, S. C. Lu, P. D. Henry, and C. H. Chen. 2001. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet activating factor-like phospholipids. Circulation. 104: 588–593.[Abstract/Free Full Text]

  8. Maziere, C., M. Djavahery-Mergny, M. Auclair, and J. C. Maziere. 1994. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine decreases the susceptibility of low-density lipoprotein to oxidative modification by copper ions, monocytes or endothelial cells. Biochim. Biophys. Acta. 1210: 233–238.[Medline]

  9. Balestrieri, M. L., L. Servillo, and T-c. Lee. 1997. The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells. J. Biol. Chem. 272: 17431–17437.[Abstract/Free Full Text]

  10. Balestrieri, M. L., K. Malik, C. Balestrieri, and T-c. Lee. 1998. Types of purinoceptors and phospholipase A2 involved in the activation of the platelet-activating factor-dependent transacetylase activity in arachidonate release by ATP in endothelial cells. Prostaglandins Other Lipid Mediat. 56: 363–375.[CrossRef][Medline]

  11. Balestrieri, M. L. and T. Lee. 2000. Regulation of the biosynthesis of acyl analogs of platelet-activating factor by purinergic agonist in endothelial cells. FEBS Lett. 479: 63–66.[CrossRef][Medline]

  12. van der Vliet, A., M. L. Hu, C. A. O'Neill, C. E. Cross, and B. Halliwell. 1994. Interactions of human blood plasma with hydrogen peroxide and hypochlorus acid. J. Lab. Clin. Med. 124: 701–707.[Medline]

  13. Vepa, S., W. M. Scribner, N. L. Parinandi, D. English, J. G. Garcia, and V. Natarajan. 1999. Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells. Am. J. Physiol. 277: L150–L158.[Abstract/Free Full Text]

  14. Bloiun, E., L. Halbwachs-Mecarelli, and P. Rieu. 1999. Redox regulation of beta2-integrin CD11b/CD18 activation. Eur. J. Immunol. 29: 3419–3431.[CrossRef][Medline]

  15. Clement, M. V., A. Ponton, and S. Pervaiz. 1998. Apoptosis induced by hydrogen peroxide is mediated by decreased superoxide anion concentration and reduction of intracellular milieu. FEBS Lett. 440: 13–18.[CrossRef][Medline]

  16. Naseem, K. M., and K. R. Bruckdorfer. 1995. Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets. Biochem. J. 310: 149–153.

  17. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915–920.[Medline]

  18. Alexander, R. W. 1995. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammarory response: a new prospective. Hypertension. 25: 155–161.[Abstract/Free Full Text]

  19. Nijveldt, R. J., E. van Nood, D. E. van Hoorn, P. G. Boelens, K. van Norren, and P. A. van Leeuwen. 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74: 418–425.[Abstract/Free Full Text]

  20. Yanoshita, R., H. W. Chang, K. H. Son, I. Kudo, and Y. Samejima. 1996. Inhibition of lysoPAF acetyltransferase activity by flavonoids. Inflamm. Res. 45: 546–549.[CrossRef][Medline]

  21. Manthey, J. A., K. Grohmann, and N. Guthrie. 2001. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr. Med. Chem. 8: 135–153.[Medline]

  22. Lindahl, M., and C. Tagesson. 1997. Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2. Inflammation. 21: 347–356.[CrossRef][Medline]

  23. Freedman, J. E., C. Parker, L. Li, J. A. Perlman, B. Frei, V. Ivanov, L. R. Deak, M. D. Iafrati, and J. D. Folts. 2001. Selected flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation. 103: 2792–2798.[Abstract/Free Full Text]

  24. Gerristein, M. E., W. W. Carley, G. E. Ranges, C. Shen, S. A. Phan, G. F. Ligon, and C. Perry. 1995. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am. J. Path. 147: 278–292.[Abstract]

  25. Aviram, M., and B. Fuhrman. 1998. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cell: role of prooxidants vs. antioxidants. Mol. Cell. Biochem. 188: 149–159.[CrossRef][Medline]

  26. Koga, T., and M. Meydani. 2001. Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells. Am. J. Clin. Nutr. 73: 941–948.[Abstract/Free Full Text]

  27. Furman, C., J. Lebeau, J. Fruchart, J. Bernier, P. Duriez, N. Cotelle, and E. Teissier. 2001. Di-tert-butylhydroxylated flavonoids protect endothelial cells against oxidized LDL-induced cytotoxicity. J. Biochem. Mol. Toxicol. 15: 270–278.[Medline]

  28. Bligh, E. G., and W. T. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 261: 911–917.

  29. Camussi, G., C. Tetta, M. C. Deregibus, G. Bussolino, G. Segoloni, and A. Vercellone. 1982. Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition. J. Immunol. 128: 86–94.[Medline]

  30. Anderson, M. E. 1985. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113: 548–555.[Medline]

  31. Test, S. T., and S. J. Weiss. 1984. Quantitative and temporal characterization of extracellular H2O2 pool generated by human neutrophils. J. Biol. Chem. 259: 399–405.[Abstract/Free Full Text]

  32. Matsuzawa, A., K. Hattory, J. Akoi, H. Arai, and K. Inoue. 1997. Protection against oxidative stress-induced cell death by intracellular platelet-activating factor acetylhydrolase II. J. Biol. Chem. 272: 32315–32320.[Abstract/Free Full Text]

  33. Simon, M. R. J., and Y. H. Lip. 1997. Free radicals and antioxidants in cardiovascular disease. Br. J. Clin. Pharmacol. 44: 307–317.[CrossRef][Medline]

  34. Galati, G., M. Y. Moridani, T. S. Chan, and P. J. O'Brien. 2001. Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin:glutathione oxidation and conjugation. Free Radic. Biol. Med. 30: 370–382.[CrossRef][Medline]

  35. Nagata, H., S. Takekoshi, T. Takagi, T. Honma, and K. Watanabe. 1999. Antioxidative action of flavonoids, quercetin and catechin, mediated by the activation of glutathione peroxidase. Tokai J. Exp. Clin. Med. 24: 1–11.[Medline]

  36. Diaz, M. N., B. Frei, J. A. Vita, and J. F. Keaney. 1997. Antioxidants and atherosclerotic heart disease. N. Engl. J. Med. 337: 408–416.[Free Full Text]

  37. Tsoukatos, D. C., T. A. Liapikos, A. D. Tselepis, M. J. Chapman, and E. Ninio. 2001. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. Biochem. J. 357: 457–464.[CrossRef][Medline]

  38. Singh, I., K. Pahan, M. Khan, and A. K. Singh. 1998. Cytokine-mediated induction of ceramide production is redox-sensitive. J. Biol. Chem. 273: 20354–20362.[Abstract/Free Full Text]

  39. Clay, K. L., C. Jonson, and G. S. Worthen. 1991. Biosynthesis of platelet activating factor and 1-O-acyl analogues by endothelial cells. Biochim. Biophys. Acta. 1094: 43–50.[Medline]

  40. Whatley, R. E., K. L. Clay, F. H. Chilton, M. Triggiani, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1992. Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. Prostaglandins. 43: 21–29.[CrossRef][Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 FASEB J.Home page
L. Servillo, C. Balestrieri, A. Giovane, P. Pari, D. Palma, G. Giannattasio, M. Triggiani, and M. L. Balestrieri
Lysophospholipid Transacetylase in the Regulation of Paf Levels in Human Monocytes and Macrophages
FASEB J, May 1, 2006; 20(7): 1015 - 1017.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M200292-JLR200v1
44/2/380    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balestrieri, M. L.
Right arrow Articles by Servillo, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balestrieri, M. L.
Right arrow Articles by Servillo, L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Advertisement
spacer
Advertisement
Advertisement